The US Food and Drug Administration (FDA) has granted accelerated approval for PTC Therapeutics’ KEBILIDI, the first gene ...

PTC Therapeutics (NASDAQ:PTCT) has received FDA approval for its gene replacement therapy Kebilidi for the treatment of ...

The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene ...

This system will become Sara and it is expected to enter the Gulf of Mexico next week. Could it impact Florida? How?

PTC 19 is a broad area of low pressure over the central Caribbean Sea. It continues to produce a large area of disorganized showers and thunderstorms. Conditions are conducive for development, and a ...

It is too soon to discuss any impacts that Florida could experience from Potential Tropical Cyclone 19 / Sara.

Raising and narrowing 2024 guidance ranges: Adjusted EBITDA of $750 to $780 million and Adjusted Free Cash Flow of $265 to $285 million. Reaffirming 2025 guidance ranges: Adjusted EBITDA of $925 to $1 ...

Improvements to premium tax credits, enacted in the American Rescue Plan and extended by the Inflation Reduction Act, have ...

We are tracking the newly designated Potential Tropical Cyclone 19, which is forecast to head into the Gulf of Mexico next week. We are tracking the newly designated Potential Tropical Cyclone 19, ...

Kebilidi is the first gene therapy approved by the FDA for administration directly into the brain, given via a cannula during ...

Multibagger Stock: PTC Industries, an engineering component manufacturer, has experienced a remarkable surge in its share ...